uterus_001:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma
  biomarker_profile: "MLH1 and PMS2 protein expression lost by IHC. MSH2 and MSH6 retained. MSI-high by PCR. TMB 45 mut/Mb. TP53 wild-type. HER2 negative (0+). PIK3CA H1047R mutation detected."

uterus_002:
  morphology: CARCINOSARCOMA
  descriptive_name: Uterine carcinosarcoma
  biomarker_profile: "TP53 p.R273H mutation identified"

uterus_003:
  morphology: ADENOCARCINOMA
  descriptive_name: Grade 3 endometrioid carcinoma
  biomarker_profile: "Mismatch repair proficient. MSI-stable. No actionable mutations detected."

uterus_004:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial cancer
  biomarker_profile: "MSH6 mutation c.3261dup (pathogenic). MSI-H confirmed. TMB elevated at 28 mutations per megabase. ERBB2 amplification absent. PIK3CA E545K present. p53 shows wild-type staining pattern."

uterus_005:
  morphology: ADENOCARCINOMA
  descriptive_name: Serous endometrial carcinoma
  biomarker_profile: "TP53 R248Q. HER2 3+ by immunohistochemistry, FISH ratio 4.2 (amplified). MMR intact."

uterus_006:
  morphology: CARCINOSARCOMA
  descriptive_name: MMMT
  biomarker_profile: "No biomarkers tested per clinical discretion"

uterus_007:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrioid adenocarcinoma, FIGO grade 2
  biomarker_profile: "All four MMR proteins preserved. Microsatellite stable. PIK3CA wild type."

uterus_008:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine corpus adenocarcinoma
  biomarker_profile: "MSI testing: high. TMB: 52.3 mut/Mb (high)"

uterus_009:
  morphology: ADENOCARCINOMA
  descriptive_name: Clear cell carcinoma of endometrium
  biomarker_profile: "MSI-L. TP53 p.Y220C. HER2 neg. PIK3CA mutation absent. PMS2 intact, MLH1 intact, MSH2 intact, MSH6 intact."

uterus_010:
  morphology: CARCINOSARCOMA
  descriptive_name: Malignant mixed Müllerian tumor
  biomarker_profile: "TP53 c.818G>A (p.R273H) mutation detected by NGS"

uterus_011:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenoca
  biomarker_profile: "MMR deficient (MLH1 methylated)"

uterus_012:
  morphology: ADENOCARCINOMA
  descriptive_name: High-grade endometrial carcinoma
  biomarker_profile: "TP53 mutant (p.G245S). HER2/neu 2+ equivocal, FISH not amplified. MSI-stable. TMB low at 2.1 mut/Mb. PIK3CA H1047L mutation present."

uterus_013:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrioid carcinoma
  biomarker_profile: "Microsatellite instability high"

uterus_014:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine papillary serous carcinoma
  biomarker_profile: "p53 overexpression (>90% strong nuclear staining). HER2 amplification detected by ISH. MMR proficient."

uterus_015:
  morphology: CARCINOSARCOMA
  descriptive_name: Uterine carcinosarcoma
  biomarker_profile: "Molecular testing not performed"

uterus_016:
  morphology: ADENOCARCINOMA
  descriptive_name: Grade 1 endometrioid adenocarcinoma
  biomarker_profile: "MLH1/PMS2 loss. MSI-H. TMB 31 muts/Mb. PIK3CA E542K."

uterus_017:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial CA
  biomarker_profile: "MSH2 c.388_389del frameshift mutation. MSI-high status confirmed. Tumor mutation burden elevated (18.4 mutations/megabase). TP53 wild-type. ERBB2 not amplified."

uterus_018:
  morphology: ADENOCARCINOMA
  descriptive_name: Mixed endometrial carcinoma
  biomarker_profile: "TP53 mutation detected. MMR intact. HER2 1+."

uterus_019:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrium adenocarcinoma
  biomarker_profile: "No alterations identified"

uterus_020:
  morphology: CARCINOSARCOMA
  descriptive_name: Uterine CS
  biomarker_profile: "TP53 p.R175H somatic mutation"

uterus_021:
  morphology: ADENOCARCINOMA
  descriptive_name: UPSC
  biomarker_profile: "TP53 p.R248W. HER2 amplified (ratio 6.1). PIK3CA WT. MMR proteins all retained."

uterus_022:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma, endometrioid type
  biomarker_profile: "MSI-H by PCR-based assay. TMB high (42 mut/Mb). MLH1 promoter hypermethylation present. PIK3CA p.Q546R mutation detected. p53 wild-type pattern."

uterus_023:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine cancer
  biomarker_profile: "MSI stable"

uterus_024:
  morphology: ADENOCARCINOMA
  descriptive_name: Dedifferentiated endometrial carcinoma
  biomarker_profile: "MMR deficient - MSH6 loss with preserved MLH1, MSH2, PMS2. MSI-high. TP53 mutated."

uterus_025:
  morphology: CARCINOSARCOMA
  descriptive_name: Carcinosarcoma of uterus
  biomarker_profile: "TP53 Y163C identified on liquid biopsy"

uterus_026:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma
  biomarker_profile: "MMR-proficient, MSS, TMB-low"

uterus_027:
  morphology: ADENOCARCINOMA
  descriptive_name: Gr2 endometrioid carcinoma
  biomarker_profile: "PIK3CA mutation p.E545K detected. Mismatch repair proteins intact by IHC. TP53 shows wild-type staining."

uterus_028:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine corpus malignancy
  biomarker_profile: "MSH2 and MSH6 absent on immunostaining. MSI testing confirms high instability. TMB: 67 mutations/Mb"

uterus_029:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial carcinoma
  biomarker_profile: "HER2 negative"

uterus_030:
  morphology: CARCINOSARCOMA
  descriptive_name: Malignant mixed mesodermal tumor
  biomarker_profile: "p53 mutation c.733G>A"

uterus_031:
  morphology: ADENOCARCINOMA
  descriptive_name: Type II endometrial cancer
  biomarker_profile: "TP53 p.C176Y. HER2 score 3+ (positive). PIK3CA p.H1047R co-mutation. MMR intact."

uterus_032:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrioid adenoca, FIGO 1
  biomarker_profile: "MLH1 methylation detected. MSI-H. TMB 23 mut/Mb."

uterus_033:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine adenocarcinoma
  biomarker_profile: "Comprehensive genomic profiling revealed no targetable alterations"

uterus_034:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial cancer, serous type
  biomarker_profile: "p53 mutant type staining (null pattern). ERBB2 amplification present (FISH ratio 4.8). Microsatellite stable. PIK3CA wild-type."

uterus_035:
  morphology: CARCINOSARCOMA
  descriptive_name: Uterine carcinosarcoma
  biomarker_profile: "TP53 R280K"

uterus_036:
  morphology: ADENOCARCINOMA
  descriptive_name: EC
  biomarker_profile: "MSI-high"

uterus_037:
  morphology: ADENOCARCINOMA
  descriptive_name: Well-differentiated endometrioid carcinoma
  biomarker_profile: "All MMR proteins retained. MSS. PIK3CA E542K mutation. TP53 wt."

uterus_038:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine neoplasm
  biomarker_profile: "PMS2 germline mutation c.736_741delins mutation identified. MSI-H. TMB elevated."

uterus_039:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma NOS
  biomarker_profile: "Limited panel: MMR intact, TP53 wild-type"

uterus_040:
  morphology: CARCINOSARCOMA
  descriptive_name: MMMT of uterus
  biomarker_profile: "No mutations detected in TP53"

uterus_041:
  morphology: ADENOCARCINOMA
  descriptive_name: High-grade serous carcinoma
  biomarker_profile: "TP53 p.R273C detected. HER2 2+ by IHC, FISH negative (ratio 1.2). MMR proteins preserved. PIK3CA p.E545K present."

uterus_042:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma
  biomarker_profile: "MSI-H, TMB-H (38 mut/Mb), MLH1/PMS2 deficient"

uterus_043:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine malignancy
  biomarker_profile: "NGS panel: No actionable variants"

uterus_044:
  morphology: ADENOCARCINOMA
  descriptive_name: Grade 3 endometrioid CA
  biomarker_profile: "MSH6 loss by IHC. MSI high by NGS. TMB 19.8 mutations per megabase. TP53 p.Y220C mutation co-occurring."

uterus_045:
  morphology: CARCINOSARCOMA
  descriptive_name: Uterine heterologous carcinosarcoma
  biomarker_profile: "TP53 missense mutation identified"

uterus_046:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial carcinoma
  biomarker_profile: "PIK3CA positive"

uterus_047:
  morphology: ADENOCARCINOMA
  descriptive_name: Corpus uteri cancer
  biomarker_profile: "Intact DNA mismatch repair system. Microsatellite stable. HER2 0. TP53 wild type sequence."

uterus_048:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrioid endometrial adenocarcinoma
  biomarker_profile: "Lynch syndrome confirmed: MSH2 germline deletion. MSI-H. TMB 55 mut/Mb. PIK3CA H1047R."

uterus_049:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine adenocarcinoma
  biomarker_profile: "HER2 IHC 1+ (negative)"

uterus_050:
  morphology: CARCINOSARCOMA
  descriptive_name: CS
  biomarker_profile: "TP53 p.R175H detected at VAF 45%"

uterus_051:
  morphology: ADENOCARCINOMA
  descriptive_name: Mixed serous and endometrioid carcinoma
  biomarker_profile: "TP53 p.G245D. HER2 amplified. MSI-stable. PIK3CA E545K also detected."

uterus_052:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial cancer
  biomarker_profile: "MSI-H"

uterus_053:
  morphology: ADENOCARCINOMA
  descriptive_name: Low-grade endometrioid adenocarcinoma
  biomarker_profile: "MMR proficient (all 4 proteins intact). Microsatellite stable. TMB low. No PIK3CA mutations."

uterus_054:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine adenocarcinoma, endometrioid
  biomarker_profile: "MLH1 promoter hypermethylation positive. MSI-high. TMB 29 mutations/Mb."

uterus_055:
  morphology: CARCINOSARCOMA
  descriptive_name: Uterine sarcomatoid carcinoma
  biomarker_profile: "Molecular profiling pending"

uterus_056:
  morphology: ADENOCARCINOMA
  descriptive_name: EEC
  biomarker_profile: "PIK3CA p.H1047L"

uterus_057:
  morphology: ADENOCARCINOMA
  descriptive_name: Papillary serous carcinoma of endometrium
  biomarker_profile: "p53 overexpressed (>95% cells). HER2/neu 3+ positive. MMR intact. PIK3CA wild-type."

uterus_058:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma
  biomarker_profile: "Complete MMR deficiency panel negative"

uterus_059:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine carcinoma
  biomarker_profile: "MSH2: absent, MSH6: absent, MLH1: retained, PMS2: retained. MSI-H confirmed."

uterus_060:
  morphology: CARCINOSARCOMA
  descriptive_name: Biphasic uterine tumor
  biomarker_profile: "TP53 p.R280T"

uterus_061:
  morphology: ADENOCARCINOMA
  descriptive_name: Undifferentiated carcinoma
  biomarker_profile: "MSI-H. TMB very high (89 mut/Mb). MLH1 methylated. TP53 mutated. HER2 negative."

uterus_062:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma, grade 2
  biomarker_profile: "Biomarker analysis: MMR-p, MSS, TMB-L"

uterus_063:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine cancer
  biomarker_profile: "No biomarkers detected"

uterus_064:
  morphology: ADENOCARCINOMA
  descriptive_name: Clear cell endometrial carcinoma
  biomarker_profile: "TP53 p.R248Q mutation. HER2 non-amplified. MSI-stable. MMR intact."

uterus_065:
  morphology: CARCINOSARCOMA
  descriptive_name: Carcinosarcoma, NOS
  biomarker_profile: "TP53 alteration present"

uterus_066:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrioid carcinoma with squamous differentiation
  biomarker_profile: "PIK3CA E545K and H1047R double mutation"

uterus_067:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine adenoca
  biomarker_profile: "Mismatch repair deficient: PMS2 lost, MLH1 lost, MSH2 intact, MSH6 intact"

uterus_068:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial carcinoma, type I
  biomarker_profile: "All molecular markers within normal limits"

uterus_069:
  morphology: ADENOCARCINOMA
  descriptive_name: USC
  biomarker_profile: "TP53 p.Y205C. HER2 amplification ratio 8.2. PIK3CA p.E542K co-mutation."

uterus_070:
  morphology: CARCINOSARCOMA
  descriptive_name: Müllerian adenosarcoma
  biomarker_profile: "TP53 immunohistochemistry shows mutant pattern"

uterus_071:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma
  biomarker_profile: "TMB-high at 41 mut/Mb"

uterus_072:
  morphology: ADENOCARCINOMA
  descriptive_name: Grade 1 endometrial carcinoma
  biomarker_profile: "PIK3CA mutation absent. MMR proteins all present. TP53 wild-type staining pattern. HER2 0."

uterus_073:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial neoplasm
  biomarker_profile: "Microsatellite instability detected (MSI-H). Hypermutated phenotype with TMB of 33.7 mut/Mb."

uterus_074:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine corpus adenocarcinoma
  biomarker_profile: "ERBB2 not amplified"

uterus_075:
  morphology: CARCINOSARCOMA
  descriptive_name: Mixed epithelial and mesenchymal tumor
  biomarker_profile: "Insufficient tissue for molecular testing"

uterus_076:
  morphology: ADENOCARCINOMA
  descriptive_name: Serous ECA
  biomarker_profile: "TP53 c.742C>T (p.R248W). HER2 IHC 2+, FISH amplified (ratio 3.1)."

uterus_077:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma
  biomarker_profile: "MSH6 germline mutation carrier. MSI-H phenotype confirmed."

uterus_078:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine carcinoma
  biomarker_profile: "Standard panel negative"

uterus_079:
  morphology: ADENOCARCINOMA
  descriptive_name: Moderately differentiated endometrioid carcinoma
  biomarker_profile: "MLH1 and PMS2 proteins absent. MSI-high. TMB 26.4 mutations per megabase. PIK3CA p.Q546R. TP53 wild-type."

uterus_080:
  morphology: CARCINOSARCOMA
  descriptive_name: Uterine MMT
  biomarker_profile: "TP53 splice site mutation detected"

uterus_081:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial cancer
  biomarker_profile: "PIK3CA mut+"

uterus_082:
  morphology: ADENOCARCINOMA
  descriptive_name: High-grade endometrial adenocarcinoma
  biomarker_profile: "TP53 p.R175H mutation. HER2 score 0. MSI-stable. PIK3CA wild-type. TMB 3.2 mut/Mb (low)."

uterus_083:
  morphology: ADENOCARCINOMA
  descriptive_name: Corpus uteri adenocarcinoma
  biomarker_profile: "MSI analysis: stable"

uterus_084:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrioid carcinoma, FIGO 3
  biomarker_profile: "MSH2 loss confirmed by IHC and germline testing. MSI-H. TMB elevated at 44 mut/Mb."

uterus_085:
  morphology: CARCINOSARCOMA
  descriptive_name: Heterologous carcinosarcoma
  biomarker_profile: "TP53 gene mutation confirmed"

uterus_086:
  morphology: ADENOCARCINOMA
  descriptive_name: EA
  biomarker_profile: "HER2-, MMRp, MSS"

uterus_087:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine serous carcinoma
  biomarker_profile: "Comprehensive profiling: TP53 p.G245S, HER2 amplified (3+ IHC, FISH+), PIK3CA p.H1047R, MMR intact"

uterus_088:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial adenocarcinoma
  biomarker_profile: "All tested markers negative"

uterus_089:
  morphology: ADENOCARCINOMA
  descriptive_name: Mixed endometrial adenocarcinoma
  biomarker_profile: "MLH1 hypermethylation present. MSI-high status. TMB 37 mutations/megabase."

uterus_090:
  morphology: CARCINOSARCOMA
  descriptive_name: Uterine tumor, biphasic
  biomarker_profile: "TP53 p.V157F at 62% allele frequency"

uterus_091:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrioid adenocarcinoma, well-differentiated
  biomarker_profile: "Molecular testing unremarkable"

uterus_092:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine carcinoma, high-grade
  biomarker_profile: "TP53 mutation p.Y220C. HER2 IHC 1+ (negative). MSI testing: stable. PIK3CA: no mutations detected."

uterus_093:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial cancer
  biomarker_profile: "TMB: 8.3 mut/Mb"

uterus_094:
  morphology: ADENOCARCINOMA
  descriptive_name: Papillary serous adenocarcinoma
  biomarker_profile: "p53 aberrant (null pattern). ERBB2 gene amplified by FISH. MMR proficient by IHC."

uterus_095:
  morphology: CARCINOSARCOMA
  descriptive_name: Carcinosarcoma of the uterus
  biomarker_profile: "Next-generation sequencing: TP53 p.R282W"

uterus_096:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial carcinoma, endometrioid type, grade 2
  biomarker_profile: "PIK3CA H1047R mutation detected. MMR intact. TP53 wild-type pattern. HER2 not amplified. MSI-stable."

uterus_097:
  morphology: ADENOCARCINOMA
  descriptive_name: Uterine adenocarcinoma
  biomarker_profile: "MSI-high, TMB-high"

uterus_098:
  morphology: ADENOCARCINOMA
  descriptive_name: Endometrial CA, mixed histology
  biomarker_profile: "Complex molecular profile: MSH6 deficient, MSI-H, TMB 62 mut/Mb, TP53 p.R273H, PIK3CA p.E545K"

uterus_099:
  morphology: ADENOCARCINOMA
  descriptive_name: Low-grade EEC
  biomarker_profile: "No significant molecular alterations"

uterus_100:
  morphology: CARCINOSARCOMA
  descriptive_name: Malignant mixed Müllerian tumor of uterine corpus
  biomarker_profile: "TP53 c.524G>A (p.R175H) somatic mutation detected by targeted sequencing"